Biosimilar Guidance: Brands Try Again For A Pre-Approval Requirement

Trade associations representing largely brand manufacturers in the U.S. and Europe want FDA to release guidance on biosimilars before approving any applications, even though the law was written so the agency does not have to wait for guidance to conduct reviews.